Analyst Chalres Zhu works at GUGGENHEIM and is focused on the Healthcare sector with 38 price targets and ratings documented since 2019 spanning on 6 stocks. Analyst's average stock valuation to be materialised ratio is 22.22% with an average time for price targets to be met of 44 days.
Most recent stock forecast was given on MGNX, MacroGenics, Inc at 23-Nov-2022.
Chalres Zhu best performing recommendations are on ZYME (ZYMEWORKS INC).
The best stock recommendation documented was for ZYME (ZYMEWORKS INC) at 11/20/2019. The price target of $48 was fulfilled within 58 days with a profit of $9.24 (23.84%) receiving and performance score of 4.11.
Average potential price target upside
